← The MYKO Library
Foundations · Adaptogens

What "adaptogen" actually means — and what it doesn't

The term gets stretched thin in marketing copy, applied to anything from goji berries to caffeine. The original definition is much narrower — and much more useful — than the supplement industry treats it.

Lazarev's three criteria, 1947

Soviet pharmacologist Nikolai Lazarev coined "adaptogen" in 1947 to describe a class of compounds with three specific properties: (1) they produce a non-specific increase in resistance to physical, chemical, and biological stressors; (2) they normalize physiological function regardless of the direction of disruption (lowering it if too high, raising it if too low — the "bidirectional" property); and (3) they're nontoxic at therapeutic doses with minimal side effects.

That third criterion is the one most modern usage ignores. By the strict definition, caffeine is not an adaptogen (it doesn't normalize bidirectionally — it only stimulates). Most things sold as "adaptogenic herbs" don't qualify either, because they only push in one direction or have meaningful side-effect profiles at therapeutic doses.

The mushrooms that actually qualify

Of the medicinal mushrooms used in MYKO formulas, four meet all three Lazarev criteria with strong supporting evidence:

  • Reishi (Ganoderma lucidum) — the canonical bidirectional immune modulator and HPA-axis modulator
  • Chaga (Inonotus obliquus) — bidirectional inflammatory modulation plus the highest ORAC score in nature
  • Cordyceps (Cordyceps militaris) — bidirectional energy/cortisol regulation through AMPK and adenosine pathways
  • Turkey Tail (Trametes versicolor) — Tier-1 immune modulation with documented bidirectional effect on T-cell populations

Lion's Mane sits in a gray area — it's broadly safe and bidirectional in its effect on cognitive baselines, but it's more accurately classified as a nootropic than a strict adaptogen.

Why bidirectional matters

Most supplements push in one direction. Caffeine raises alertness. Melatonin lowers it. Vitamin D raises immune activity. NSAIDs lower it. These are useful tools but they're not adaptogens — they don't normalize, they push.

An adaptogen senses what the body needs and corrects toward homeostasis. Reishi will calm an overactive immune system in autoimmune contexts and raise a sluggish one in immunocompromised contexts. The same molecule, opposite effects.

This is the property that makes adaptogenic mushrooms distinctively valuable as foundational daily supplements. They're not quick fixes; they're terrain modifiers. Build the substrate and the rest of the formula has clean conditions to work in.

← Back to the Library Continue reading Integration as the missing layer in microdosing protocols →
The MYKO Journal

One note a month. No promotions.

When something new lands in the Library — a new monograph, a lab-result drop, a protocol guide — we'll send a single note. No tracking pixels. Unsubscribe anytime.

One email per month. Your address stays with us — never sold, never shared.